Reading FMCB? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track FMCB free→Reading FMCB? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track FMCB free→QuarterlyIQ Insights · FMCB
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 4 valuation methods, at three horizons. Current price $1321.00. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| Mgmt guidance | 12M | $1685.48 | 12.6 | 133.96 | Mgmt | high |
| Peer P/B | 12M | $1213.30 | 1.4 | 860.17 | TTM | high |
| Peer P/E | 12M | $1623.49 | 12.6 | 129.03 | TTM | high |
| Peer P/S | 12M | $1129.13 | 2.9 | 390.04 | TTM | high |
| Peer P/B | 3Y |
Monthly trailing P/E with quartile reference lines.
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
| $1419.79 |
| 1.4 |
| 1006.56 |
| Hist. CAGR(prov.) |
| medium |
| Peer P/S | 3Y | $1437.44 | 2.9 | 496.54 | Hist. CAGR(prov.) | medium |
| Peer P/B | 5Y | $1576.62 | 1.4 | 1117.75 | Hist. CAGR(prov.) | high |
| Peer P/S | 5Y | $1688.44 | 2.9 | 583.24 | Hist. CAGR(prov.) | high |